Back to Rankings

AKAN

AkandaA
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-06-02
View Chart
+
Peers tracked
8
U.S. public peers
Grade Position
Above peers
vs peer average
AKAN vs peer average
93/100
AKAN vs. peer average (A vs. D)
Grade spread
A 1 · B 1 · D 1 · F 3
Graded peers loaded
Coverage
8 graded
100% of tracked

Peer overview

IMNN is the first available peer comparator.

Same sector: Pharmaceuticals, Biotechnology & Life Sciences · Cap $9.04M

Peer source comes from the stored AI memo or peer model
Grades and factor rows use RankAlpha API data when available
Missing peer scores remain blank instead of being estimated
Side-by-side comparison keeps the data contract visible
Top peerIMNNImunon
AKAN
Akanda
IMNN
Imunon
Grade
A
A
Momentum
100
93
Value
41
41
Sentiment
-
76
Setup Bias
Net Neutral
-
Market Cap
-
-
Posture
Constructive
Constructive

Grade position vs IMNN

AKAN / IMNN
Grade Position
Above peers
AKAN vs. peer average (A vs. D)
93/100
Momentum
100
AKAN
Value
41
AKAN
Sentiment
-
-

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank
Ticker
Company
Grade
Grade score
vs AKAN
1
IMNN
Imunon Inc Common
A
100/100
Even
2
NCNA
NuCana plc ADR
F
20/100
+4
3
SNES
SenesTech Inc Common
B
80/100
+1
4
QNRX
Quoin Pharmaceuticals. Ltd ADR
D
40/100
+3
5
CURX
Curanex Pharmaceuticals Inc Common
N/A
-
-
IMNN is the first peer returned for this comparison set.